Bellerophon Therapeutics BLPH
€ 0.10
-74.18%
Quartalsbericht 2023-Q3
hinzugefügt 14.11.2023
Bellerophon Therapeutics Bilanz 2011-2024 | BLPH
Bilanz Jährlich Bellerophon Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-23.8 M | -45.9 M | -7.56 M | -16.6 M | -28.8 M | -14.5 M | -6.26 M | -16.8 M | - | - | - | |
Langfristige Schulden |
- | 203 K | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
203 K | 752 K | 704 K | 658 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 1.93 M | 6.96 M | 32.3 M | 5.22 M | - | - | 5.38 M | 3.25 M | - |
Kurzfristige Verbindlichkeiten |
5.4 M | 5.05 M | 10.4 M | 7.58 M | 7.54 M | 7.08 M | 6.5 M | 8.07 M | - | - | - | - |
Gesamtverbindlichkeiten |
5.4 M | 5.26 M | 12 M | 9.52 M | 14.5 M | 39.4 M | 11.7 M | 8.07 M | 10.5 M | 19.4 M | 14.5 M | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-252 M | -232 M | -214 M | -190 M | -176 M | -179 M | -124 M | -101 M | -54.2 M | -177 M | -115 M | - |
Vermögenswerte |
7.94 M | 26.9 M | 50.2 M | 13.1 M | 18.4 M | 36.8 M | 29.7 M | 38.4 M | 33.4 M | 3.64 M | 3.35 M | - |
Zahlungsmittel |
6.92 M | 24.7 M | 47.6 M | 9.87 M | 16.6 M | 28.8 M | 14.5 M | 6.26 M | 16.8 M | - | - | - |
Buchwert |
2.53 M | 21.6 M | 38.2 M | 3.59 M | 3.86 M | -2.59 M | 18 M | 30.3 M | 22.9 M | -15.7 M | -11.1 M | - |
Gesamtes Eigenkapital |
2.53 M | 21.6 M | 38.2 M | 3.59 M | 3.86 M | -2.59 M | 18 M | 30.3 M | 22.9 M | -15.7 M | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Bellerophon Therapeutics
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | - | - | - | - | 8 K | 203 K | 396 K | 586 K | 773 K | 956 K | 956 K | 956 K | 956 K | 1.66 M | 1.66 M | 1.66 M | 1.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
1.26 M | 5.62 M | 5.36 M | 5.4 M | 5.18 M | 5.45 M | 5.58 M | 5.26 M | 5.52 M | 6.98 M | 9.06 M | 12 M | 12 M | 12 M | 12 M | 9.52 M | 9.52 M | 9.52 M | 9.52 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 39.4 M | 39.4 M | 39.4 M | 39.4 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 8.07 M | 8.07 M | 8.07 M | 8.07 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-256 M | -254 M | -249 M | -252 M | -247 M | -242 M | -238 M | -232 M | -228 M | -223 M | -220 M | -214 M | -214 M | -214 M | -214 M | -190 M | -190 M | -190 M | -190 M | -176 M | -176 M | -176 M | -176 M | -179 M | -179 M | -179 M | -179 M | -124 M | -124 M | -124 M | -124 M | -101 M | -101 M | -101 M | -101 M | -54.2 M | -54.2 M | -54.2 M | -54.2 M | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
4.98 M | 11.2 M | 16 M | 7.94 M | 12.6 M | 17.7 M | 21.7 M | 26.9 M | 31.3 M | 37.1 M | 42.2 M | 50.2 M | 50.2 M | 50.2 M | 50.2 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 18.4 M | 18.4 M | 18.4 M | 18.4 M | 36.8 M | 36.8 M | 36.8 M | 36.8 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 38.4 M | 38.4 M | 38.4 M | 38.4 M | 33.4 M | 33.4 M | 33.4 M | 33.4 M | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
4.38 M | 10.6 M | 15.2 M | 6.92 M | 11.3 M | 16.3 M | 20 M | 24.7 M | 28.7 M | 34.3 M | 39.7 M | 47.6 M | 47.6 M | 47.6 M | 47.6 M | 9.87 M | 9.87 M | 9.87 M | 9.87 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 14.2 M | 14.5 M | 14.5 M | 14.5 M | 6.26 M | 6.26 M | 6.26 M | 6.26 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
3.72 M | 5.62 M | 10.6 M | 2.53 M | 7.43 M | 12.3 M | 16.2 M | 21.6 M | 25.8 M | 30.1 M | 33.1 M | 38.2 M | 38.2 M | 38.2 M | 38.2 M | 3.59 M | 3.59 M | 3.59 M | 3.59 M | 3.86 M | 3.86 M | 3.86 M | 3.86 M | -2.59 M | -2.59 M | -2.59 M | -2.59 M | 18 M | 18 M | 18 M | 18 M | 30.3 M | 30.3 M | 30.3 M | 30.3 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
3.72 M | 5.62 M | 10.6 M | 2.53 M | 7.43 M | 12.3 M | 16.2 M | 21.6 M | 25.8 M | 30.1 M | 33.1 M | 38.2 M | 38.2 M | 38.2 M | 38.2 M | 3.59 M | 3.59 M | 3.59 M | 3.59 M | 3.86 M | 3.86 M | 3.86 M | 3.86 M | -2.59 M | -2.59 M | -2.59 M | -2.59 M | 18 M | 18 M | 18 M | 18 M | 30.3 M | 30.3 M | 30.3 M | 30.3 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | -15.7 M | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung